Acquisition of a Leica Bond Rx Controller
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Place of performance
- Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute (NCI), operating under the Department of Health and Human Services Office of the Assistant Secretary for Administration, has issued a Notice of Intent to award a sole source purchase order to Ferox LLC of Ellicott City, Maryland. The NCI intends to procure a Leica Bond Rx Controller, an automated immunohistochemistry stainer, under the authority of Federal Acquisition Regulation (FAR) Subpart 13.106-1(b). This special notice represents the government's intention to negotiate directly with a single source rather than conduct a competitive solicitation. The applicable NAICS code is 811210 (Electronic and Precision Equipment Repair and Maintenance) with a $34 million size standard. The procurement will be processed using Simplified Acquisition Procedures, and award is contingent upon approval of the Sole Source Justification.
The Bond Rx Controller will support critical clinical research at NCI, specifically enabling validation of immunohistochemistry target markers for diagnostic purposes and enrollment into NIH clinical trials focused on rare tumor identification and therapeutic mechanism development. The acquisition includes a one-year warranty and recommended preventative maintenance with a PM Kit following instrument relocation, with a one-year period of performance. Interested parties have until January 27, 2026—seven days from the posting date of January 21, 2026—to submit a written statement of capabilities demonstrating their ability to meet the requirement. There are no formal eligibility restrictions beyond the requirement to demonstrate capability to provide the specified equipment and services. If no affirmative responses are received within the seven-day window, the government will proceed with award to Ferox LLC; however, the government retains discretion to conduct a competitive procurement based on responses received. Inquiries regarding this notice should be directed to Elizabeth Bulger at Elizabeth.bulger@hhs.gov.
Notice text
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE ORDER AND NOT A REQUEST FOR QUOTATIONS.
This contract action is for the acquisition of supplies/equipment for which the Government intends to solicit and negotiate with only one source under the authority of Federal Acquisition Regulation (FAR) Subpart 13.106-1(b). The National Cancer Institute (NCI) intends to award a single source purchase order to Ferox LLC, Ellicott City, MD, for the acquisition of a Leica Bond Rx Controller.
The National Cancer Institute (NCI) needs to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.
The anticipated period of performance will be for one year.
The applicable North American Industry Classification System (NAICS) code for this acquisition is 811210 – Electronic and Precision Equipment Repair and Maintenance and a size standard of $34M.
NCI will solicit and negotiate directly with Ferox LLC and no solicitation will be issued. Interested parties may identify their interest and capability. Award is subject to approval of the Sole Source Justification. This notice of intent is not a request for competitive proposals or quotations; however, an interested party may submit a statement of capabilities if they believe they can meet the above requirement. The statement of capabilities must be submitted in writing and contain sufficient detail to allow the Government to determine if the party can provide the requirement. A determination by the Government not to compete this proposed action based upon responses to this notice is solely with the discretion of the Government. All responses must be received within 7 days from the date of publication of this synopsis. Information received will normally be considered for the purpose of determining whether to conduct a competitive procurement. If no affirmative responses are received within 7 days of this notice, an award will be made to Ferox LLC. This procurement is to be processed using Simplified Acquisition Procedures. There is no solicitation package available. For any questions regarding this announcement, please contact Elizabeth Bulger via email Elizabeth.bulger@hhs.gov
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Leica Bond Rx Controller | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity